AS PHARMA CONSULTING

Active

Private limited companyfounded 20233 yrs activeAvenue de la Gare(FL) 14, 6220 Fleurus, BelgiumKBO/BCE: BE 0802.302.143

Summary

The computed 12-month bankruptcy probability of AS PHARMA CONSULTING is 2.0% (moderate). The 2025 annual accounts show equity of €129k and a net result of €29k. Its solvency ranks better than 80% of 18400 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysis Watch Report Compare

AS PHARMA CONSULTINGActiveChecked score 72/100

Risk analysis Report Compare

Checked score

Score 2025

72 / 100

Healthy

Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability58▼-42

Solvency95▼-1

Growth52

Track record94

Bankruptcy probability, 12 months

2.0% Moderate

0%0.5%1.5%4%10%≥ 25%

Credit up to €9k at 30 days acceptable

Liquidity ample (current ratio 2.96 against 2.88 in 2024; short-term debt: 30.2% and cash: 72.2% of total assets), and 30.2% of the assets are financed with debt.

Credit check for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

Higher-failure-rate sector

In this sector companies fail more often than the Belgian average.

Gazette · bankruptcies per sector, NACE 47

Relative position

BE, all sectors

reference

Retail trade (NACE 47)

about 45% more bankruptcies

← fewer bankruptcies more bankruptcies →

Annual accounts: healthy financial profile

The latest annual accounts show a healthy profile in solvency, result and liquidity.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

69.8%

Return on assets

15.4%

Age of the figures

9 mo

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Filed after the deadline

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 2 filings

Deviation from the deadline

2025

27 d late

2024

28 d late

← before the deadline after the deadline →

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

25-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity

€129k▲ 28.3%

2024 · €101k

2024: €101k 2025: €129k▲ +28.3% vs 2024

2024 → 2025

Total assets

€186k▲ 30.0%

2024 · €143k

2024: €143k 2025: €186k▲ +30.0% vs 2024

2024 → 2025

Net result

€29k▼ 70.7%

2024 · €97k

2024: €97k 2025: €29k▼ -70.7% vs 2024

2024 → 2025

Working capital

€110k▲ 40.1%

2024 · €79k

2024: €79k 2025: €110k▲ +40.1% vs 2024

2024 → 2025

Trend over the years

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20242025Trend

Equity€101k-€129k▲ 28.3% 2024: €101k 2025: €129k▲ +28.3% vs 2024

Operating result€130k-€78k▼ 40.2% 2024: €130k 2025: €78k▼ -40.2% vs 2024

Net result€97k-€29k▼ 70.7% 2024: €97k 2025: €29k▼ -70.7% vs 2024

Turnover and EBIT margin not published: the micro schema does not require them.

Result per fiscal year

Operating resultNet result

The operating result falls in 2025; 2025 is 40% below 2024.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €186k

10%

89.6%

Fixed assets €19k ▼ 13.3%

Current assets €166k ▲ 38.0%

Equity and liabilities €186k

69.8%

30.2%

Equity €129k ▲ 28.3%

Debt €56k ▲ 34.1%

Debt's share of the balance-sheet total rises from 29.3% to 30.2%. Equity and debt are higher.

Key figures and ratios

2025 value · change against 2024

EBITDA

€81k▼

2024 · €134k

Cash flow

€32k▼

2024 · €101k

Current ratio

2.96▲

2024 · 2.88

Debt to equity

0.43▲

2024 · 0.42

ROE

22.1%▼

2024 · 96.5%

ROA

15.4%▼

2024 · 68.2%

Interest coverage

2.38▼

2024 · 23.15

Debt ≤ 1 year

€56k▲

2024 · €42k

Income taxes

€15k▼

2024 · €28k

Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

As filed By statement

Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines

Balance sheet Code20242025

Assets

Total assets20/58€143k€186k▲

Fixed assets21/28€22k€19k▼

Intangible fixed assets21€17k€15k▼

Tangible fixed assets22/27€5k€4k▼

Plant, machinery and equipment23€4k€4k▼

Furniture and vehicles24€1k€602▼

Current assets29/58€120k€166k▲

Amounts receivable within one year40/41€16k€30k▲

Trade receivables40€16k€22k▲

Other amounts receivable41-€9k

Cash at bank and in hand54/58€103k€134k▲

Deferred charges and accrued income490/1€2k€2k▼

Equity and liabilities

Total equity and liabilities10/49€143k€186k▲

Equity10/15€101k€129k▲

Contributions10/11€4k€4k=

Reserves13€97k€126k▲

Distributable reserves133€97k€126k▲

Profit (loss) carried forward14€40€4▼

Amounts payable17/49€42k€56k▲

Amounts payable within one year42/48€42k€56k▲

Trade debts44€2k€3k▲

Suppliers440/4€2k€3k▲

Taxes, remuneration and social security45€10k€17k▲

Taxes450/3€10k€17k▲

Remuneration and social security454/9€160-

Other amounts payable47/48€30k€35k▲

Income statement Code20242025

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€3k▼

Other operating charges640/8€4k€656▼

Gross operating margin9900€138k€82k▼

Operating profit (loss)9901€130k€78k▼

Financial income75/76B€382€0▼

Recurring financial income75€382€0▼

Financial charges65/66B€6k€34k▲

Recurring financial charges65€6k€34k▲

Profit (loss) for the period before taxes9903€125k€44k▼

Income taxes67/77€28k€15k▼

Profit (loss) for the period9904€97k€29k▼

Profit (loss) for the period to be appropriated9905€97k€29k▼

Appropriation of the result

Profit (loss) to be appropriated9906€97k€29k▼

Profit (loss) brought forward from the previous period14P-€40

Transfer to equity691/2€97k€29k▼

To other reserves6921€97k€29k▼

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement

Income statement Balance sheet Cash flow

Line	2024	2025	Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630	€4k	€3k	▼ 19.5%
Other operating charges640/8	€4k	€656	▼ 81.4%
Gross operating margin9900	€138k	€82k	▼ 40.7%
Operating profit (loss)9901	€130k	€78k	▼ 40.2%
Financial income75/76B	€382	€0	▼ 100.0%
Recurring financial income75	€382	€0	▼ 100.0%
Financial charges65/66B	€6k	€34k	▲ 488%
Recurring financial charges65	€6k	€34k	▲ 488%
Profit (loss) for the period before taxes9903	€125k	€44k	▼ 64.8%
Income taxes67/77	€28k	€15k	▼ 44.3%
Profit (loss) for the period9904	€97k	€29k	▼ 70.7%
Profit (loss) for the period to be appropriated9905	€97k	€29k	▼ 70.7%

Line	2024	2025	Change
Assets
Total assets20/58	€143k	€186k	▲ 30.0%
Fixed assets21/28	€22k	€19k	▼ 13.3%
Intangible fixed assets21	€17k	€15k	▼ 11.8%
Tangible fixed assets22/27	€5k	€4k	▼ 18.3%
Plant, machinery and equipment23	€4k	€4k	▼ 10.6%
Furniture and vehicles24	€1k	€602	▼ 46.4%
Current assets29/58	€120k	€166k	▲ 38.0%
Amounts receivable within one year40/41	€16k	€30k	▲ 93.3%
Trade receivables40	€16k	€22k	▲ 38.6%
Other amounts receivable41	-	€9k	-
Cash at bank and in hand54/58	€103k	€134k	▲ 30.5%
Deferred charges and accrued income490/1	€2k	€2k	▼ 4.9%
Equity and liabilities
Total equity and liabilities10/49	€143k	€186k	▲ 30.0%
Equity10/15	€101k	€129k	▲ 28.3%
Contributions10/11	€4k	€4k	=
Reserves13	€97k	€126k	▲ 29.4%
Distributable reserves133	€97k	€126k	▲ 29.4%
Profit (loss) carried forward14	€40	€4	▼ 90.9%
Amounts payable17/49	€42k	€56k	▲ 34.1%
Amounts payable within one year42/48	€42k	€56k	▲ 34.1%
Trade debts44	€2k	€3k	▲ 117%
Suppliers440/4	€2k	€3k	▲ 117%
Taxes, remuneration and social security45	€10k	€17k	▲ 74.0%
Taxes450/3	€10k	€17k	▲ 76.8%
Remuneration and social security454/9	€160	-	-
Other amounts payable47/48	€30k	€35k	▲ 16.8%

Line	2024	2025	Change
Profit (loss) for the period9904	€97k	€29k	▼ 70.7%
+ Depreciation and write-downs630	€4k	€3k	▼ 19.5%
Operating cash flow (approximation)	€101k	€32k	▼ 68.8%
Investment in fixed assets (approximation)	-	€0	-
Change in cash	-	€31k	-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Timeline · acts, filings and financial milestones

All 2Filings 2

Next filing, fiscal year 2026, expected by 31-07-2027

2026

27-08

NBB filing Annual accounts filed

fiscal year 2025 · micro schema · 27 days late

2025

28-08

NBB filing Annual accounts filed

fiscal year 2024 · micro schema · 28 days late

NBB filing

0 of 1 act read

About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors

1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.

Location & real-estate footprint

Registered office, Fleurus · 1 establishment unit since 2023

seat establishment The establishment unit on the map

Ground area

425 m²

Building footprint

183 m²

Volume, LiDAR

2,561 m³

Parcel 52021C0178/00T000, Wallonia · tallest building 15.7 m, ±5 floors. Linked by address, not a title deed.

1 establishment unit

AS PHARMA CONSULTING

Avenue de la Gare(FL) 14, 6220 FleurusRetail sale of pharmaceutical products

since 20232.345.774.259

1 parcel

Wallonia 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
52021C0178/00T000	Wallonia	425 m²	1 · 183 m²	15.7 m · 5 fl.

Linked by address, not proof of ownership

Good to know

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

254900CI9LTEA7D55V08

live in the LEI register

Similar companies · same sector, comparable size

APOTHEEK ELZEDORP

BE 0466.358.479

Sint-Katelijne-Waver · Eq €129,380

PINTELON

BE 0439.708.126

Oostkamp · Eq €129,349

APOTHEEK MINNAERT

BE 0421.589.219

Oosterzele · Eq €129,256

APOTHEEK FRANCOIS CLAEYS

BE 0775.499.855

Knokke-Heist · Eq €129,230

Apo Kuipers

BE 0642.552.348

Lubbeek · Eq €129,208

Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,531 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification

Legal formPrivate limited company

Founded01-06-2023

Fiscal year end31-12

Activities, NACEBEL 2025

47730Retail sale of pharmaceutical products

47750Retail sale of cosmetics and toilet articles

70200Business and other management consultancy

82990Other business support services

Contact

E-mail siracusa.antho.pharma@gmail.com

Scores and ratios are computed by Checked and are not a credit decision.